{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-082167","form_type":"8-K","ticker":null,"cik":"0001868573","company_name":"APx Acquisition Corp. I","filed_at":"2024-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.165657+00:00","generated_at":"2026-06-04T05:33:59.447522+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"APx Acquisition Corp. I enters definitive business combination agreement with OmnigenicsAI and MultiplAI Health","bullets":["SPAC APXI to merge with OmnigenicsAI; each SPAC share exchanged for one OmnigenicsAI ordinary share.","Backstop agreement provides up to $10M from Theo I SCSp to cover any shortfall in trust cash plus PIPE.","Closing conditions include shareholder approval, SEC registration effectiveness, Nasdaq listing, and at least $5M net tangible assets.","Sponsor and Parent (Heritas) entered voting and support agreement to vote in favor of the business combination."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-082167","json":"https://secwatch.observer/filing/0001193125-24-082167.json","markdown":"https://secwatch.observer/filing/0001193125-24-082167.md","text":"https://secwatch.observer/filing/0001193125-24-082167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1868573/000119312524082167/0001193125-24-082167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1868573/000119312524082167/d808624d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T05:33:59.447522+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"53ded9c90f50401063be78c37f4da67bbc6f5051","claim":"APx Acquisition Corp. I entered into Business Combination Agreement with OmnigenicsAI Corp, Heritas Merger Sub Limited, and MultiplAI Health Ltd (effective 2024-03-25).","evidence_excerpt":"On March 25, 2024, APx Acquisition Corp. I (the “Company”), OmnigenicsAI Corp, a Cayman Islands exempted company (“OmnigenicsAI”), Heritas Merger Sub Limited, a Cayman Islands exempted company and a direct wholly-owned subsidiary of OmnigenicsAI (“Merger Sub”) and MultiplAI Health Ltd, a private limited company formed under the laws of England and Wales (“MultiplAI” and, together with OmnigenicsAI, the “Target Companies”), entered into a Business Combination Agreement (the “Business Combination Agreement”","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1868573/000119312524082167/0001193125-24-082167-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"OmnigenicsAI Corp, Heritas Merger Sub Limited, and MultiplAI Health Ltd"},{"label":"Effective","value":"2024-03-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}